MSI2 and cervical carcinoma: Furthermore, it triggers the progression of ovarian and cervical cancers by sequestering miR-128-3p and promoting the expression of cyclin-dependent kinase 14 (CDK14) and RNA-binding protein Musashi-2 (MSI2) [10,51].